English
-
Activist guide to Hepatitis C diagnostics
Produced by the Treatment Action Group (TAG), the Activist Guide outlines major barriers to accessing testing technologies and services.
-
WHO List of Essential Medicines
The World Health Organization (WHO) updates its essential list of medicines every two years.
-
100% LIFE – 2018 Annual Report
Our partner, 100% LIFE, is the largest patient organization in Ukraine. 100% LIFE employs a range of strategies in order...
-
LACTA Community Advisory Board (CAB) – 2018 Report
Treatment activists, representing 13 countries in the Latin America and Caribbean region (LACTA), met with ViiV Healthcare in Panama City...
-
Join the Fight – Celebrating HIV Activism Then and Now
This ITPC film looks back at how we started, what’s changed and why community activism is still needed now more...
-
MedsPaL – patent information database
MedsPaL provides information on the patent and licensing status of selected HIV, Hepatitis C, TB and other patented essential medicines...
-
The Roadmap – Special Edition Report on Tenofovir Alafenamide Fumarate (TAF)
Make Medicines Affordable partner, the Initiative for Medicines, Access and Knowledge (I-MAK), has produced the Roadmap Special Edition Report on...
-
Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
This intellectual property landscapes tool developed in the MENA region can be used to assess the patent landscape in other countries.
-
EU-Mercosur Bi-regional Association Agreement
The impact of intellectual property on public procurement of medicines in Argentina. This report analyzes the potential impact on access...